Author: William Green

  • Elimination and Reintroduction: The Clinical Protocol for Finding Your Triggers

    Elimination and reintroduction is the most clinically rigorous self-assessment tool available for identifying food-related symptom triggers. In my reading of the literature, it is also consistently performed incorrectly by people attempting it independently — with the result that they either fail to identify real triggers because the elimination was inadequate, or they falsely implicate foods because the reintroduction was unstructured. The protocol matters enormously.

    Phase 1: Elimination

    The elimination phase is designed to create a clean baseline — a symptom-free state from which the effect of individual food reintroduction can be clearly observed. This requires that the elimination be both sufficiently broad and sufficiently long. The American Academy of Allergy, Asthma and Immunology (AAAAI) recommends a minimum of two to four weeks for the elimination phase, with some practitioners extending to six weeks for conditions like eosinophilic esophagitis.

    The standard comprehensive elimination removes all nine major allergens: cow’s milk and dairy products, eggs, fish, shellfish, tree nuts, peanuts, wheat and gluten-containing grains, soy, and sesame. Any foods the individual personally suspects based on their symptom pattern should also be removed. Hidden sources of these allergens in processed foods require careful label reading — many packaged foods contain milk powder, wheat starch, or soy lecithin in forms that are not immediately obvious.

    What I find important to clarify here is that the elimination diet must be nutritionally adequate. Removing dairy without adequate calcium and vitamin D replacement, or removing multiple protein sources without compensatory planning, creates nutritional risk that is independent of and in addition to whatever food triggers are being investigated. Working with a registered dietitian during the elimination phase is not optional for people with complex diets or multiple suspected triggers — it is clinically advisable.

    Phase 2: Systematic Reintroduction

    The reintroduction phase is where most self-guided attempts fail. The fundamental principle is one food group at a time, with sufficient waiting period between introductions to allow any delayed reactions to fully manifest before a new food is added. Standard protocol: introduce the target food two to three times in the first day (breakfast and dinner, for example); if no symptoms develop on day one, continue monitoring for two to three additional days before introducing the next food group. Delayed reactions — GI symptoms, eczema flares, nasal congestion — can occur up to 72 hours after the provoking exposure.

    Symptoms to track fall into several categories. Gastrointestinal: bloating, abdominal pain, diarrhea, constipation, nausea. Dermatological: hives, eczema flare, flushing, rash. Respiratory: nasal congestion, runny nose, postnasal drip. Systemic and cognitive: fatigue, brain fog, joint pain, headache. A detailed written symptom log — not memory — is required. Pattern recognition across multiple reintroduction challenges is what makes the data actionable.

    The sequence of reintroduction can be guided by clinical suspicion: foods the individual is most confident are safe can be reintroduced first, establishing that the baseline is maintained, before proceeding to more suspect foods. Each food challenge should use a typical serving size of that food in a pure form — not in a mixed dish where multiple potential triggers are present simultaneously.

    Phase 3: Maintenance and Ongoing Management

    Once triggers are identified through systematic reintroduction, the maintenance phase involves building a personalized long-term diet that avoids confirmed triggers while being as nutritionally complete and socially functional as possible. Unnecessary restriction — eliminating foods that were tolerated during reintroduction — should be avoided. Dietary restriction has its own costs: nutritional adequacy, quality of life, social functioning, and the risk of developing anxiety around food.

    Dose-dependence is an important concept in maintenance. Some people who react to a food at large quantities tolerate small amounts without symptoms. Systematic dose escalation — progressively larger amounts of a borderline food introduced in a structured way — can define a personal threshold below which the food can be incorporated. Periodic re-testing of eliminated foods is also appropriate, as many food sensitivities (particularly in children) resolve over time, and a food that triggered symptoms two years ago may be tolerated today.

    The Safety Line: When You Must See a Clinician

    The critical safety boundary in self-guided elimination-reintroduction is any history of systemic or severe reactions. If any past reaction to a food involved throat tightening, difficulty breathing, loss of consciousness, vomiting within minutes of exposure, or use of an epinephrine auto-injector — do not self-guide. Full stop. These reactions indicate potential IgE-mediated anaphylaxis, and reintroduction of the implicated food outside of a supervised medical setting carries life-threatening risk. Oral food challenges for foods with anaphylaxis history must be conducted by a board-certified allergist in a clinical setting with emergency equipment and staffing available.

    Self-guided protocols are appropriate for people with GI symptoms, mild skin reactions (chronic eczema, non-urticarial rashes), or chronic fatigue in the complete absence of any history of systemic reactions. The presence of any respiratory symptoms with food exposure — even mild congestion — warrants allergist evaluation before proceeding.

    Formal Allergy Testing Options

    When self-guided elimination-reintroduction is insufficient or contraindicated, formal allergy evaluation offers several diagnostic tools. Skin prick testing is rapid, office-based, and has high sensitivity for IgE-mediated allergy — a positive result (wheal-and-flare response) indicates IgE sensitization, though it must be correlated with clinical history to confirm clinically relevant allergy. Specific IgE blood testing via ImmunoCAP measures circulating IgE antibodies to individual food proteins and is useful when skin testing cannot be performed (severe eczema, certain medications, young children). The oral food challenge — graded doses of the suspected food given under medical supervision with objective monitoring — is the diagnostic gold standard for both confirming and ruling out food allergy. A negative oral food challenge definitively clears a food; a positive challenge confirms clinically relevant reactivity and guides management decisions.

    Not medical advice. Content is informational only. Consult a qualified healthcare provider before making changes to your health regimen.

  • The Hygiene Hypothesis: Why Allergy Rates Are Rising and What the Research Shows

    Allergy rates have risen substantially in developed countries over the past several decades, with the steepest increases in the latter half of the twentieth century. In my reading of the literature, this is one of the more compelling examples of an environmental mismatch hypothesis gaining serious empirical support — though the mechanism is considerably more specific than the original formulation suggested.

    The Original Strachan Hypothesis

    David Strachan’s 1989 paper in the BMJ is the foundational text. Strachan analyzed data from a large British birth cohort and found that hay fever prevalence decreased with increasing family size — children with more older siblings had lower rates of allergic disease. He proposed that early childhood infections transmitted by older siblings provided protective exposure that prevented allergic sensitization. The formulation that emerged from this finding — that improved hygiene was depriving children of infection exposure necessary to train the immune system — became known as the hygiene hypothesis.

    The hypothesis was compelling in its simplicity and in its potential to explain the epidemiological pattern of rising allergy rates coinciding with industrialization, improved sanitation, and decreased infectious disease burden in developed countries. However, subsequent research refined and substantially modified the original formulation in important ways.

    The “Old Friends” Refinement

    Graham Rook (2012), in PNAS, proposed the “old friends” hypothesis as a more mechanistically precise reformulation. Rook’s central argument is that the relevant exposures are not infections from other children — which are evolutionarily recent and often genuinely harmful — but specifically the organisms with which humans co-evolved over hundreds of thousands of years: helminths (parasitic worms), saprophytic mycobacteria from soil and water, and commensal organisms from natural environments. These “old friends” were omnipresent in the human ancestral environment and appear to have trained the immune regulatory system — specifically Treg cell populations producing IL-10 and TGF-beta — to maintain appropriate tolerance and avoid inflammatory overreaction.

    What I find important to clarify here is that this reframing changes the implication dramatically. The original hygiene hypothesis could be misread as arguing against cleanliness or sanitation. The old friends hypothesis argues against the specific loss of exposure to evolutionarily co-evolved organisms — not general dirt or common childhood infections. Modern sanitation, vaccines, and antibiotics for bacterial infections are not the targets of this critique.

    The Ege Farm Study

    Ege et al. (2011), published in the New England Journal of Medicine, provided some of the most striking epidemiological evidence for the old friends framework. The PARSIFAL study compared rates of asthma, hay fever, and atopic sensitization in farm-raised children in rural Europe versus non-farm rural children in the same regions. Farm-raised children had dramatically lower rates of allergic disease — not merely lower, but in some categories several-fold lower.

    Crucially, the investigators examined which specific farm exposures correlated most strongly with protection. The most protective factors were consumption of raw farm milk, regular contact with farm animals, and time in farm stables. Simply living in a rural area without farm contact provided substantially less protection. This points toward specific microbial exposures from farm environments — the microbiome of animals, hay, soil, and unpasteurized milk — rather than rural lifestyle factors in general.

    Antibiotic Use and the Microbiome Connection

    Martin Blaser’s work at NYU has documented a related pathway: early childhood antibiotic use and its effects on the developing microbiome. Antibiotic courses in early life alter microbiome composition in ways that persist and that are associated in longitudinal studies with increased risk of allergic disease, asthma, and obesity. Helicobacter pylori — a bacterium that colonized the human stomach for tens of thousands of years before being largely eliminated in developed countries through antibiotic use and improved sanitation — has been associated in some studies with reduced asthma risk. Its near-universal eradication in developed populations represents another loss of an “old friend” co-evolved organism, with potentially complex immunological consequences.

    These findings do not argue against treating bacterial infections with antibiotics when clinically indicated. They argue for thoughtful antibiotic stewardship — avoiding unnecessary courses in early childhood when the microbiome is being established — and for the development of microbiome-preserving antibiotic strategies.

    What This Means and Doesn’t Mean Practically

    The LEAP study (Du Toit et al., 2015, New England Journal of Medicine) is the clearest translation of old friends hypothesis principles into clinical action. The study demonstrated that early, regular introduction of peanuts in high-risk infants (those with severe eczema or known egg allergy) reduced the development of peanut allergy by approximately 80% compared to avoidance. This overturned decades of clinical guidance recommending avoidance of major allergens in high-risk infants and is now reflected in current guidelines recommending early allergen introduction.

    What this body of evidence supports: microbiome diversity in early life is important; excessive and unnecessary antibiotic use in early childhood warrants more conservative prescribing practices; early allergen introduction is beneficial rather than harmful in most infants. What it does not support: avoiding vaccines, deliberately exposing children to infections, abandoning basic hygiene, or expecting probiotic supplement products to meaningfully substitute for the complex microbial exposures the farm environment research describes. Supplements are single or limited-strain products; the relevant microbial diversity is orders of magnitude greater in complexity.

    Not medical advice. Content is informational only. Consult a qualified healthcare provider before making changes to your health regimen.

  • Food Allergy vs Food Sensitivity: The Clinical Distinction That Changes Everything

    The terms “food allergy” and “food sensitivity” are used interchangeably in popular discourse, but in clinical medicine they describe mechanistically distinct phenomena with fundamentally different implications for safety, diagnosis, and management. In my reading of the literature, conflating these categories is not merely imprecise — it can be genuinely dangerous, and it contributes significantly to unnecessary dietary restriction and missed diagnoses.

    IgE-Mediated Allergy: Immediate and Potentially Dangerous

    True food allergy, as defined in clinical immunology, is an IgE-mediated immune response. IgE antibodies specific to a food protein bind to mast cells and basophils throughout the body. Upon re-exposure to the allergen, cross-linking of surface IgE triggers rapid degranulation — the release of histamine, prostaglandins, leukotrienes, and other mediators that produce the classic allergic response.

    The timing is characteristically rapid: symptoms typically appear within minutes to two hours of ingestion. The spectrum ranges from mild (localized urticaria, oral itching) to life-threatening anaphylaxis — a systemic reaction involving throat swelling, bronchospasm, cardiovascular collapse, and loss of consciousness. People with known IgE-mediated food allergy require strict allergen avoidance and must carry injectable epinephrine (epi-pen) at all times. There is no dose-dependent threshold below which exposure is safe for most individuals with confirmed IgE-mediated allergy; even trace contamination can trigger systemic reactions in highly sensitized individuals.

    Diagnosis requires clinical correlation between IgE testing and symptoms. The available tests include skin prick testing (high sensitivity, office-based, produces a wheal-and-flare response in sensitized individuals) and specific IgE blood testing via ImmunoCAP — measuring circulating IgE antibodies to specific food proteins. Neither test alone is diagnostic; both must be interpreted in the context of the individual’s clinical history by a board-certified allergist.

    Non-IgE Reactions: Delayed and Dose-Dependent

    Non-IgE-mediated food reactions encompass a broader and less well-characterized category of adverse responses. Cell-mediated delayed hypersensitivity reactions involve T-cell pathways rather than IgE and produce symptoms over hours to days rather than minutes. Food protein-induced enterocolitis syndrome (FPIES) is one example, occurring primarily in infants and young children.

    What I find important to clarify here is that many reactions people experience and label as food allergies are non-immune in mechanism — food intolerances involving enzyme deficiencies (lactase deficiency producing lactose intolerance), pharmacological responses to compounds in food (histamine intolerance, caffeine sensitivity), or osmotic and fermentation effects of certain carbohydrates. These are real, uncomfortable, and worth addressing — but they do not carry the anaphylaxis risk of IgE-mediated allergy and are typically dose-dependent, meaning reduction rather than complete elimination is often adequate management.

    The Major Allergens

    The NIAID (National Institute of Allergy and Infectious Diseases) food allergy guidelines identify eight major allergens that collectively account for approximately 90% of IgE-mediated food allergies in the United States: cow’s milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, and soy. Food labeling laws in the US require declaration of these allergens. In 2023, sesame was added as a ninth major allergen, reflecting epidemiological evidence of its rising prevalence as an allergenic food in the US population.

    FODMAP: When It’s Not Actually Allergy

    The FODMAP framework, developed by Gibson and Shepherd at Monash University and published in Alimentary Pharmacology & Therapeutics (2010), describes a category of fermentable carbohydrates that produce GI symptoms through an entirely non-immune mechanism: osmotic activity and rapid fermentation in the colon. Fermentable oligosaccharides, disaccharides, monosaccharides, and polyols draw water into the intestinal lumen and are rapidly fermented by colonic bacteria, producing gas, bloating, altered bowel habit, and pain in susceptible individuals — particularly those with irritable bowel syndrome (IBS).

    This framework explains a clinically important observation: many people who believe they react to wheat are not reacting to gluten (the protein that triggers celiac disease and non-celiac gluten sensitivity) but to fructans — the FODMAP carbohydrates in wheat. Similarly, reactions to onions, garlic, apples, and certain legumes are frequently FODMAP-mediated. The low-FODMAP diet is now a first-line dietary intervention for IBS management with strong RCT evidence behind it — but it addresses a functional GI mechanism, not an immune mechanism.

    The IgG Testing Problem

    Commercial food sensitivity testing measuring IgG antibodies to panels of foods is widely marketed and persistently popular. The American Academy of Allergy, Asthma and Immunology (AAAAI) and the European Academy of Allergy and Clinical Immunology (EAACI) have both issued position statements stating clearly that IgG food testing is not a validated diagnostic tool for food intolerance or allergy. IgG antibodies to food proteins develop in response to food exposure and are a marker of normal immune tolerance — not of pathological reactivity. Elevated IgG to a food means you have eaten that food; it does not mean you are reacting adversely to it. These tests produce long lists of “reactive” foods that lead to unnecessary elimination of nutritionally important foods without clinical benefit.

    Why This Distinction Can Be Life-or-Death

    The clinical stakes of misclassification are asymmetric. Treating a FODMAP intolerance as though it were an IgE-mediated allergy results in unnecessary restriction and food anxiety — suboptimal but manageable. Treating a true IgE-mediated food allergy as though it were a sensitivity, and attempting dose-escalation or gradual reintroduction outside of medical supervision, can trigger anaphylaxis. Any individual with a history of systemic reactions to a food — particularly reactions involving respiratory symptoms, throat swelling, or loss of consciousness — must be evaluated by a board-certified allergist rather than self-managing through commercial sensitivity panels or elimination-reintroduction protocols.

    Not medical advice. Content is informational only. Consult a qualified healthcare provider before making changes to your health regimen.